BrainCheck Celebrates U.S. FDA Approval of Leqembi®
BrainCheck Celebrates U.S. FDA Approval of Leqembi® and Empowers Customers […]
BrainCheck Celebrates U.S. FDA Approval of Leqembi® Read More »
BrainCheck Celebrates U.S. FDA Approval of Leqembi® and Empowers Customers […]
BrainCheck Celebrates U.S. FDA Approval of Leqembi® Read More »
AUSTIN, Texas, June 1st, 2023 – BrainCheck is partnering with
AUSTIN, Texas, March 28, 2023 – We are thrilled to
We’re Thrilled to Announce Kim Rodriguez as Our New CEO! Read More »
In healthcare clinics across the nation, assessing cognitive health has
Measuring Cognitive Health With Digital Cognitive Assessment Read More »
The fast-growing Texas-based medtech startup names industry vets Trey Swain
BrainCheck Appoints Two New Leaders to Executive Team Read More »
Original article by Christine Hall, published in TechCrunch As the
BrainCheck brings in another $10M to detect, manage cognitive impairment Read More »
From antidepressants and antipsychotics to anxiety medications and opioids, nearly
Are Prescriptions Helping or Harming Dementia Patients? Read More »
We’ve highlighted the importance of cognitive testing using many perspectives
Post-Op Patients Might be Going Home with Cognitive Impairment Read More »
An infection with COVID-19 is likely to cause lingering neurocognitive
How COVID-19 Affects the Brain Read More »
What does the approval of Biogen’s Alzheimers drug Aduhelm, along
Clinic Minute | Alzheimer’s Drug Approval & Dementia Care Read More »